Comparing the effect of edible olibanum, and curcumin on blood and inflamatory factors in rheumatoid arthritis patients
Phase 2
- Conditions
- Rheumatoid arthritis.Seropositive rheumatoid arthritis
- Registration Number
- IRCT2017011614925N2
- Lead Sponsor
- Vice chancellor for research, Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Willing to participate in study; Clinical diagnosis of rheumatoid arthritis (meeting the American college of rheumatology 1987 criteria); No smoking or addiction; No drug type and dose fluctuation since 1 month prior to the study and during intervention period ; Not having severe cardiovascular; Hepatic; Kidney; Gastrointestinal; Thyroid; Parathyroid diseases; Diabetes and inflammation; Not using medications except for AR conventional drugs; No pregnancy or lactation Exclusion criteria: Developing illnesses which need particular cures or interfere with intervention such as increasing the disease activity or trauma; alcoholic; sensitivity to olibanum and turmeric
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hs- CRP. Timepoint: Befor intervention, End of the intervention. Method of measurement: ELISA.;Blood lipid. Timepoint: Befor intervention, End of the intervention. Method of measurement: Laboratory.;Fasting insulin. Timepoint: Befor intervention, End of the intervention. Method of measurement: HOMA-IR.
- Secondary Outcome Measures
Name Time Method Serum levels of Total Antioxidant Capacity. Timepoint: Befor intervention, End of the intervention. Method of measurement: Laboratory ELISA.;Rheumatoid factor. Timepoint: Befor intervention, End of the intervention. Method of measurement: Laboratory.